Alaunos Therapeutics (TCRT) Non-cash Items (2011 - 2018)
Alaunos Therapeutics (TCRT) reported Non-cash Items of $2.9 million for Q3 2018, up 8.44% on a YoY basis from $2.7 million in Q3 2017, and up 604.7% quarter-over-quarter from $415000.0 in Q2 2018.
Alaunos Therapeutics (TCRT) Non-cash Items (2011 - 2018) Analysis & Trends
Alaunos Therapeutics has reported Non-cash Items for 8 years, with the latest figure at $2.9 million in Q3 2018.
- For the quarter ending Q3 2018, Non-cash Items rose 8.44% year-over-year to $2.9 million; the trailing twelve-month figure through Sep 2018 stood at $2.9 million (up 8.44% YoY), and the FY2017 full-year result was $1.2 million, down 66.19% from the prior year.
- Non-cash Items for Q3 2018 stood at $2.9 million, up from $415000.0 in the prior quarter.
- The five-year high for Non-cash Items was $27.5 million in Q2 2015, with the low at $415000.0 in Q2 2018.
- Historically, Non-cash Items has averaged $4.6 million across 5 years, with a median of $2.9 million in 2018.
- Annual changes were most pronounced in 2015 — Non-cash Items surged 766.78% — and 2018, when it sank 92.94%.
- Alaunos Therapeutics' Non-cash Items stood at $3.8 million in 2014, then plunged by 43.91% to $2.1 million in 2015, then climbed by 25.98% to $2.7 million in 2016, then increased by 9.49% to $2.9 million in 2017, then slipped by 0.03% to $2.9 million in 2018.
- The last three Non-cash Items figures came in at $2.9 million (Q3 2018), $415000.0 (Q2 2018), and $1.0 million (Q1 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 2.92 Mn |
| Sep 30, 2018 | 2.92 Mn |
| Jun 30, 2018 | 415,000.00 |
| Jun 30, 2018 | 415,000.00 |
| Mar 31, 2018 | 1.02 Mn |
| Mar 31, 2018 | 1.02 Mn |
| Dec 31, 2017 | 2.93 Mn |
| Dec 31, 2017 | 2.93 Mn |
| Sep 30, 2017 | 2.70 Mn |
| Sep 30, 2017 | 2.70 Mn |
| Jun 30, 2017 | 5.88 Mn |
| Jun 30, 2017 | 5.88 Mn |
| Mar 31, 2017 | 6.30 Mn |
| Mar 31, 2017 | 6.30 Mn |
| Dec 31, 2016 | 2.67 Mn |
| Dec 31, 2016 | 2.67 Mn |
| Sep 30, 2016 | 2.32 Mn |
| Sep 30, 2016 | 2.32 Mn |
| Jun 30, 2016 | 2.24 Mn |
| Jun 30, 2016 | 2.24 Mn |